Free Trial
NYSEAMERICAN:APHB

Ampliphi Biosciences (APHB) Stock Price, News & Analysis

Ampliphi Biosciences logo
$2.20 -0.01 (-0.45%)
(As of 12/11/2024 ET)

About Ampliphi Biosciences Stock (NYSEAMERICAN:APHB)

Key Stats

Today's Range
$2.11
$2.30
50-Day Range
N/A
52-Week Range
$0.15
$1.37
Volume
8,366 shs
Average Volume
842,200 shs
Market Capitalization
$73.63 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

AmpliPhi Biosciences Corporation, a biotechnology company, focuses on the development of therapies for antibiotic-resistant infections using bacteriophage-based technology. The company is involved in developing AB-SA01 for the treatment of staphylococcus aureus (S. aureus) infections; and AB-PA01 for the treatment of pseudomonas aeruginosa (P. aeruginosa) infections. It holds collaborative research and development agreements with the United States Army Medical Research and Materiel Command for the development of bacteriophage therapeutics to treat S. aureus, E. coli, and P. aeruginosa infections; and Walter Reed Army Institute of Research. The company was formerly known as Targeted Genetics Corporation and changed its name to AmpliPhi Biosciences Corporation in February 2011. AmpliPhi Biosciences Corporation was founded in 1989 and is headquartered in San Diego, California.

Receive APHB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ampliphi Biosciences and its competitors with MarketBeat's FREE daily newsletter.

APHB Stock News Headlines

Asian Pac Holdings Bhd (APHB)
[Urgent] Starlink Set For The Largest IPO In History?
He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000! And now, Elon could be set to do it for the third and final time… with what might be his biggest breakthrough yet. And for the first time ever, you have the rare chance to profit BEFORE the upcoming IPO.
See More Headlines

APHB Stock Analysis - Frequently Asked Questions

Ampliphi Biosciences Corp (NYSEAMERICAN:APHB) issued its quarterly earnings results on Monday, March, 25th. The biotechnology company reported ($0.15) earnings per share for the quarter, missing the consensus estimate of ($0.08) by $0.07.

Shares of APHB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Ampliphi Biosciences investors own include Navios Maritime Partners (NMM), Sorrento Therapeutics (SRNE), Allena Pharmaceuticals (ALNA), Actinium Pharmaceuticals (ATNM), Protalix BioTherapeutics (PLX), Athersys (ATHX) and Corbus Pharmaceuticals (CRBP).

Company Calendar

Last Earnings
3/25/2019
Today
12/11/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NYSEAMERICAN:APHB
Fax
N/A
Employees
30
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Market Cap
$73.63 million
Optionable
Not Optionable
Beta
N/A
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

This page (NYSEAMERICAN:APHB) was last updated on 12/11/2024 by MarketBeat.com Staff
From Our Partners